Cargando…
Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein
Non-alcoholic fatty liver disease (NAFLD) is a common liver disease, characterized by the excess accumulation of lipids in the liver. It has been demonstrated that the dysregulation of lipid droplet (LD)-associated proteins may be involved in the development of NAFLD. Adipose differentiation-related...
Autores principales: | LIU, FANG, WANG, CHAO, ZHANG, LIJUN, XU, YUQIAO, JANG, LINA, GU, YU, CAO, XIANGMEI, ZHAO, XIN, YE, JING, LI, QING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868560/ https://www.ncbi.nlm.nih.gov/pubmed/24253218 http://dx.doi.org/10.3892/ijmm.2013.1560 |
Ejemplares similares
-
Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
por: Woo, Shih-Lung, et al.
Publicado: (2014) -
Role of glycoprotein 78 and cidec in hepatic steatosis
por: Li, Jie, et al.
Publicado: (2017) -
Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017) -
Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022) -
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
por: Li, Zhenyang, et al.
Publicado: (2022)